Table 1.
Baseline Characteristics of the Study Population (n=281).
| Baseline Characteristics | |
|---|---|
| Demographics: | |
| Age (yrs) | 49 ± 13 |
| Gender (% Male) | 49% |
| Race: | |
| Caucasian | 61% |
| African American | 32% |
| Asian | 5% |
| Other | 2% |
| History of hypertension | 47% |
| History of Diabetes | 22% |
| Tobacco use | 49% |
| Body Mass Index (kg/m2) | 29.5 ± 6.3 |
| Serum Creatinine (mg/dL) | 0.9 ± 0.2 |
|
Use of Antihypertensive Agents By Drug Class(%) |
|
| Beta Blockers | 7% |
| ACE Inhibitors | 15% |
| Angiotensin Receptor Blockers (ARB’s) | 8% |
| Calcium Channel Blockers | 11% |
| Diuretics | 23% |
| Cardiac Function: | |
| Ejection Fraction (%) | 63 ± 6 |
| Em (cm/s) | 13.4 ± 5.7 |
| E/Em | 5.7 ± 1.8 |
| Cardiac Output (L/min) | 4.6 ± 0.1 |
| LVMI (g/m2) | 86.0 ± 18.0 |
| Vascular Function: | |
| Central SBP (mm Hg) | 115 ± 15 |
| Central DBP (mm Hg) | 80 ± 8 |
| Central PP (mm Hg) | 34 ± 11 |
| Central MAP (mm Hg) | 92 ± 10 |
| Central Augmented Pressure (mm Hg) | 9 ± 7 |
| Compliance (mL/mm Hg) | 2.3 ± 0.9 |
| Total Peripheral Resistance (dynes•sec/cm5) | 1684 ± 27 |
Values presented as mean ± standard deviation for continuous variables or percentage for categorical. Abbreviations: BSA, body surface area.